NAGE — Niagen Bioscience, Inc.

—
Nasdaq · Materials · Chemicals · CIK 1386570 ·
Last close
$1.87
Market Cap
$148.10M
52W High
$7.12
52W Low
$1.84
ADV30
547,906
Next earnings
2026-11-04

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 27,192,000 17,105,000 -1,587,000 -1,173,000 108,694,000 69,509,000 25,620,000
Jun 2026 29,785,000 19,314,000 700,000 963,000 106,589,000 66,740,000 24,061,000
Mar 2026 31,474,000 19,976,000 1,576,000 6,318,000 114,329,000 66,397,000 31,999,000
Dec 2025 33,839,000 21,704,000 2,103,000 4,132,000 106,406,000 64,636,000 29,873,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$4,882,000
Investing CF
$5,000,000
Financing CF
$-4,663,000
CapEx
$-303,000
Dividends Paid
—
Buybacks
$-5,121,000
EPS Diluted TTM
$0.12
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-158,420,000
Inventory
$20,524,000
Receivables
$6,840,000
ST Investments
—
EBIT TTM
$2,792,000
Pretax Income TTM
$11,055,000
Interest Exp TTM
—
Analysts
6

Yahoo Snapshot (yfinance, live)

Total Revenue
$122,290,000
EBITDA
$3,863,000
Free Cash Flow
$2,920,000
Enterprise Value
$97,003,280
Total Cash
$69,357,000
Total Debt
$2,077,000
Shares Out
79,196,903
Trailing EPS
$0.12
Book Value
$1.05
ROE
13.3%
ROA
1.7%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 129,423,000 14,296,000 17,382,000 106,406,000 29,873,000 76,533,000 13,504,000
Dec 2024 99,597,000 7,726,000 8,550,000 68,278,000 22,184,000 46,094,000 12,109,000
Dec 2023 83,570,000 -5,599,000 -4,938,000 54,964,000 26,508,000 28,456,000 7,117,000
Dec 2022 72,050,000 -18,628,000 -16,540,000 54,057,000 25,385,000 28,672,000 -15,098,000

TTM Snapshot

Revenues TTM
$129,084,000
NetIncome TTM
$15,991,000
OpCashFlow TTM
—
Assets (Latest)
$106,589,000
Forward EPS
$-0.06

Max Pain — expiry 2026-12-18 (volume-derived — Yahoo OI feed degraded)

max pain strike: $2.50 · spot: $1.87 · call volume: 3 · put volume: 60
Expected Move to 2026-12-18: ±$1.00 (53.48%) — implied range $0.87 – $2.87 · ATM straddle on $2.50 strike

Peers — same industry

TickerNameMarket CapLastDaily %
CRLBF Cresco Labs Inc. $146.15M $0.41 —
BAK BRASKEM SA $145.81M $0.85 —
LTBR LIGHTBRIDGE Corp $138.00M $3.56 —
FF FutureFuel Corp. $131.59M $3.00 —
ARQ Arq, Inc. $129.03M $2.92 —

News headlines (Yahoo Finance, 1h cache)

Niagen Bioscience to Present at the Sixth Annual Longevity Summit Taking Place at the Buck Institute for Research on Aging
2026-11-16 13:32 · Yahoo
Niagen Bioscience Expands HSA/FSA Payment Option for the Pharmaceutical-Grade Niagen™ At-Home Injection Kit through Niagen™ Plus
2026-11-12 13:32 · Yahoo
Niagen Bioscience Announces Participation in Upcoming Investor Conferences
2026-11-09 13:32 · Yahoo
Niagen (NAGE) Q3 2026 Earnings Call Transcript
2026-11-05 15:20 · Yahoo
Niagen Bioscience Inc Q3 2026 Earnings Call Summary
2026-11-05 13:30 · Yahoo
Niagen Bioscience Inc (NAGE) Q3 2026 Earnings Call Highlights: Cash Flow Positive Despite Sales ...
2026-11-05 11:11 · Yahoo
Niagen Bioscience (NAGE) Reports Q3 Loss, Lags Revenue Estimates
2026-11-04 23:45 · Yahoo
Niagen Bioscience: Q3 Earnings Snapshot
2026-11-04 21:55 · Yahoo
Niagen Bioscience, Inc. Reports Third Quarter 2026 Financial Results
2026-11-04 21:02 · Yahoo
Earnings Preview: Niagen Bioscience (NAGE) Q3 Earnings Expected to Decline
2026-10-28 13:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.